It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6 ⍨ 5.2 years and mean 2.1 ⍨ 2.2 repeated attempts had blastocyst transfers with a mean number of 2.5 ⍨ 0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.
Introduction
In monovular domestic animal species where embryo transfer is practised routinely, pregnancy rates for embryos fertilized and grown in vivo are around 60-75% for single embryo transfers (Hasler et al., 1995) . Even when cattle oocytes are matured in vitro before in-vitro fertilization (IVF) and embryo transfer, 30-45% of the oocytes develop to blastocysts in culture and 50% of those result in live-born calves when transferred as blastocysts to recipient mothers (Trounson et al., 1994; Hasler et al., 1995) . These observations indicate that human IVF-embryo transfer may be improved dramatically if embryos were grown under improved conditions to the blastocyst stage before transfer. In humans, the delivery rates are around 14-15% for a mean number of three cleavage stage embryos transferred on the second or third day after insemination for IVF and intracytoplasmic sperm injection (ICSI) respectively (World Collaborative Report on IVF, 1997). Clearly, the viability and implantation rate of human embryos after IVF-embryo transfer are very much lower than are obtained in monovular domestic ruminants.
One reason for the reduced viability of human embryos has been the difficulty in consistently growing them to the blastocyst stage because of suboptimal in-vitro conditions. Improved culture media formulations and co-culture systems that can yield blastulation rates as high as 55-60% are now available (Bongso et al., 1995; Gardner et al., 1998; Jones et al., 1998) . Studies on how co-culture systems produce their positive effects will help us to produce even better cell-free culture media formulations in the future. For example, it was recently shown that cultured human oviductal cells produce colony stimulating factor (CSF), leukaemia inhibitory factor (LIF), epidermal growth factor (EGF) and interleukin-6 (IL-6) in vitro, and the authors suggested that these factors may be responsible for the embryotrophic effects seen in co-culture systems (Barmat et al., 1997) . Perhaps the addition of these factors to the available improved culture media formulations may help us to generate viable day 5 or 6 embryos without the need for co-culture.
It may be possible to improve the success of assisted reproduction technology if such day 5 or 6 embryos are replaced into the uterus instead of day 2 embryos, not only because it is more physiological but also because only the hardiest of embryos will bypass the 4-to 8-cell block and survive to blastocyst and hatching stages. Furthermore, if the zona pellucida is softened enzymatically and zona-free blastocysts can be replaced, better cell-cell interactions and anchoring of the embryo to the endometrium may be expected, with hopefully improved implantation rates, reduced embryonic losses and fewer embryos replaced.
Studies were undertaken by our group to explore the effects of enzymatic treatment of the zona pellucida upon pregnancy rates and the safety of outcome after the transfer of day 5 blastocysts. Parallel ongoing studies to develop a human embryonic stem (ES) cell line (Bongso et al., 1994) by growing zona-free blastocysts on feeder layers provided interesting observations on cell-cell interactions between blastocyst and cell monolayer, offering some thoughts on the role of the zona in hatching and 'in-vitro implantation'.
Materials and methods

Patients and blastocyst culture
Nineteen patients with tubal, idiopathic or male infertility admitted for assisted reproduction technology and who gave informed consent were included in a study on transfer of zona-manipulated day 5 blastocysts. The mean (Ϯ SD) patient age was 32.6 Ϯ 5.2 (range 25-39) years, with eight (42%) aged over 35 years. In addition, eight patients (42%) had failed at least two (range 2 to 7) previous attempts at day 2 transfer. The study was approved by the National University Hospital's Research and Ethics Committee. The patients were superovulated using a downregulation protocol of gonadotrophin-releasing hormone (GnRH) agonist (Suprefact; Hoechst, Germany) and pure follicle stimulating hormone (Metrodin HP or Gonal F; Serono, Switzerland). Follicular growth was monitored by assays of plasma oestradiol concentrations and ultrasonography. When two co-dominant follicles reached 16 mm in diameter, the patients were given 5000 IU human chorionic gonadotrophin (HCG) (Profasi; Serono, Italy). At 34 h after HCG, oocytes were recovered transvaginally using ultrasound guidance. All oocytes were washed and incubated in a commercial culture medium (IVF50; Scandinavian IVF Science, Sweden) for 3-6 h at 37°C in an atmosphere of 5% CO 2 in air. Spermatozoa were prepared either by a conventional swim-up technique or using a Puresperm (Nidacon Labs, Gothenburg, Sweden) triple discontinuous gradient (40:70:90) method and each oocyte-cumulus complex was introduced into a 100 µl sperm droplet (20 000 motile spermatozoa) in IVF50 medium under oil (Ovoil; Scandinavian IVF Science) for insemination. A total of 12 (60%) cycles had oocytes injected with single spermatozoa because a male factor was the underlying cause of the subfertility. The gametes were incubated at 37°C in a sealed humidified desiccator (Billups, Rothenberg, CA, USA) gassed with 5% CO 2 , 5% O 2 and 90% N 2 . At 16-20 h after insemination, inseminated oocytes were mechanically denuded of corona and cumulus cells to determine fertilization, assessed by the presence of two distinct pronuclei and two polar bodies. Two to three twopronucleate (2PN) zygotes were cultured communally in 100 µl of fresh IVF50 medium covered with oil in 4-well plastic dishes (Nunclon; Roskilde, Denmark) and incubated at 37°C in the desiccator gassed with 5% CO 2 , 5% O 2 and 90% N 2 .
On day 2, embryos were graded at the 2-to 4-cell stage, and transferred onto monolayers of Vero cells plated in 4-well plastic dishes with 500 µl IVF50 medium, covered with oil and incubated at 37°C in the triple gas environment in a humidified desiccator. On day 3, the medium was changed to 50% IVF50 and 50% S2 medium (Scandinavian IVF Science) and on days 4 and 5 to 100% S2 medium. S2 medium was gradually introduced on day 3 to protect the embryos from osmotic shock. Between days 3 and 5, and until embryo transfer, the dishes containing embryos were housed in an atmosphere of 5% CO 2 , 5% O 2 and 90% N 2 in a humidified desiccator and no serum was used in any of the cultures.
Enzymatic treatment of zona and blastocyst transfer
On the morning of day 5 (115 h post insemination), the zonae of late cavitating, early and expanding embryos that were selected for transfer were enzymatically treated according to a slight modification of the method of Fong et al. (1997) . A late cavitating embryo was defined as a day 5 embryo with a blastocoel but without the inner cell mass (ICM) yet laid down, while an early blastocyst was a day 5 embryo with distinct ICM and clear trophoectoderm (TE) but no increase in diameter as yet. An expanding blastocyst had similar morphological characteristics to an early blastocyst, but had an increased diameter. Briefly, blastocysts were transferred to 10 IU/ml pronase (Sigma, St Louis, MO, USA) in S2 medium under oil for~1 min at 37°C in a 5% CO 2 atmosphere for initial stretching and softening of the zona. The embryos were then quickly examined on the heated stage (37°C) of an inverted microscope (ϫ400) to observe if the zona had expanded in size, was faint and if the perivitelline space had increased. If not, the embryos were incubated for a further 30-60 s. Most of the embryos had shown stretching and softening of the zona by 1 min. Just before complete disappearance of the faint zona (monitored under inverted optics) in the pronase, the blastocysts were transferred to fresh S2 medium and gently washed twice more in S2 medium and then incubated at 37°C in 5% CO 2 in air for a few hours until transfer.
Embryos were transferred with either a faint zona or zona-free 2928 after enzyme treatment. One to three blastocysts in 5 µl of S2 medium were replaced into the uterus on day 5 as atraumatically as possible, using an Edwards-Wallace transfer catheter and 1-ml tuberculin syringe. Only the inner soft part of the catheter containing the embryos was inserted into the uterine lumen, with the outer stiff part acting only as a guide at the external os of the cervix. Clinical pregnancy was diagnosed for those who showed at ultrasound (8 weeks of gestation) a fetal heart and sac; implantation rates were the total number of such sacs with heart beats over the total number of embryos replaced, expressed as a percentage. Fetal development of all pregnant patients was monitored regularly by detailed ultrasonography for skeletal and soft tissue anomalies.
Culture of zona-free blastocysts on feeder layers
Parallel studies on the growth of zona-free blastocysts on irradiated feeder layers were carried out for the development of a human ES cell line. The plan for isolation and culture of ICM cells from such blastocysts is summarized in Figure 1 . ICM cells were harvested by allowing blastocysts to hatch out naturally and completely from their zonae or by removing zonae enzymatically at the expanding blastocyst stages. Such zona-free blastocysts were placed on passaged gammairradiated (3000 rads) monolayers covered with Eagle's minimal essential medium (EMEM; Sigma) supplemented with 1000 units/ml of human LIF (HLIF; Sigma) under oil and left undisturbed in an incubator at 37°C in 5% CO 2 in air. The following types of irradiated passaged cell monolayers were used: human endometrial cells (mixed glands and stromal cells), human tubal epithelial cells, Vero cells, human fetal fibroblasts, murine fetal fibroblasts and Simm's thioguanine-ouabain-resistant (STO) cells. The EMEM (a complex enriched medium) with HLIF was changed every 24 h to prevent cell differentiation. ICM cells that attached and clumped on the feeder layer were separated mechanically, disaggregrated with 0.5% trypsin ϩ 0.53 mM EDTA under oil and re-seeded onto fresh irradiated monolayers in the presence of EMEM and HLIF. Attachment, invasion, growth and multiplication of the ICM to the feeder layer in the presence of HLIF was closely monitored. A group of eight zona-free blastocysts were grown on irradiated STO cells without HLIF to investigate whether HLIF contributed to cell-cell attachment and invasion.
Results
Zona-manipulated blastocyst transfer
The percentage of zygotes developing to blastocysts using this specific culture protocol was 68% and all 19 patients treated received zona-manipulated blastocysts on day 5. A mean (Ϯ SD) of 11.9 Ϯ 5.4 mature oocytes were collected from all patients with a mean transfer of 2.5 Ϯ 0.7 blastocysts per 2929 patient. The pregnancy outcomes of the 19 patients undergoing zona-manipulated blastocyst transfer are summarized in Table  I . The clinical pregnancy rate per cycle or per transfer was 53% (n ϭ 10) and the implantation rate 33%. The multiple pregnancy rate was 40% and, of the multiple pregnancies, two were triplets. At the time of submission of this report all pregnancies were ongoing and it is too early to report specific birth rates.
In-vitro implantation rates
During the in-vitro implantation studies for ES cell production, we observed that 18% (10/57) of blastocysts had hatching problems (Figures 2 and 3 ). These problems included: (i) inability to hatch at all; (ii) partial hatching followed by collapse of the blastocoel; and (iii) hatching at more than one point.
The attachment, invasion and growth of zona-free blastocysts on feeder layers through 3-4 days (from day 5 to day 8-9) are summarized in Table II . Of those blastocysts that hatched on their own, or of those where the zona had to be removed, 92% (83-100%) attached tightly and invaded the monolayers in the presence of HLIF, irrespective of the type and source of feeder layer cells. Also, 88% of blastocysts attached and invaded the STO cells in the absence of HLIF. There were no significant differences in the attachment capabilities between feeder layers. The ICM cells grew laterally as well as producing clumps on all feeder layers, while the TE cells were large cells proliferating in the outer areas of each explanted embryo. There was a clearly defined margin between ICM clumps and TE cells (Figure 4c f). By 3-5 days of culture, the proliferating ICM cells could be easily distinguished from the TE cells by their distinct small size, high nuclear:cytoplasmic ratios and prominent nucleoli as observed in ICM cells of other species by different workers (Piedrahita et al., 1990; Graves and Moreadith, 1993) . After mechanical separation and disaggregation, 100% of ICM cells continued to attach, grow laterally and clump on feeder layers in the first and second subcultures. It was possible to grow the ICM cells for some embryos up to four or five subcultures. With serial subculturing, the ICM cells (now putative ES cells) grew as colonies pushing the feeder layer cells away at their peripheries as they grew. The cells were alkaline phosphatase-positive and were subjected to characterization by other specific ES cell markers. The tests carried out thus far confirm that the cells are ICM subcultures and not trophoectodermal subcultures. The characterization and development of a human ES cell line will be documented separately.
Discussion
The first delivery of a normal healthy baby after transfer of blastocysts with zonae completely removed with pronase was reported by our group (Fong et al., 1997) . The results of the present study on a larger group of patients clearly demonstrate that ongoing implantation rates were quite high with zonamanipulated blastocyst transfers when compared with the more conventional uterine transfer of cleavage stage embryos on day 2. The method also appears to be safe, as no congenital anomalies have been observed on regular ultrasound monitoring and no reproductive losses have yet been observed up to 22 weeks of gestation. Thus, enzymatic treatment of the zona does not seem to interfere with implantation and sustenance of implantation to term. The high implantation rates may be due to improvements in viability of embryos brought about by the improved in-vitro system, the presence of a blastocyst at transfer, selection achieved by choosing among a larger cohort of embryos capable of development to blastocysts, and better cell-cell interaction between blastocyst and endometrium as a result of zona softening or complete zona removal. Interestingly, it has also been shown that there is a strong positive correlation between the capacity of a patient's spare embryos to develop to blastocysts in vitro and the implantation of her embryos transferred on day 3 in the same cycle (Sjogren et al., 1992) . This suggests that cohorts of embryos obtained from a patient which can develop to blastocysts may be more viable than those which cannot. It is however not known at present how the results of the transfer of zona-manipulated blastocysts will compare with those for zona-intact blastocysts.
It is important to note that even though the zona-manipulated transfers produced high implantation rates, there was also a high incidence of multiple pregnancies (40%). It would be expected that blastocysts should produce increased implantations because developmental blockage and growth retardation of apparently normal early cleavage stage embryos occurs frequently in vitro and in vivo and these will be discarded in longer-term culture (day 5-6). The reasons for the high multiple pregnancies may be due to better anchorage of blastocysts to the endometrium as a result of manipulation of the zona. The high incidence of implantation sites also alludes to the fact that the quality and viability of the blastocysts are improved by the in-vitro system, the markers used for identification are reliable (Table III) , and that the softening or absence of the zona may encourage more embryos to implant. It may therefore be mandatory for zona-manipulated blastocyst transfers in patients below 40 years of age, that one to two blastocysts be replaced rather than three to four. This will be of great advantage, as it will reduce the incidence of multiple pregnancies without compromising too much on the most optimal pregnancy rate. Alikani and Wiemer (1997) recently suggested that the transfer of one or two embryos is a good viable option for young patients, while those aged ജ40 years may be at a disadvantage.
There have been several reports showing that transfer of zona-intact late stage embryos (8-cell to blastocyst) increases the success of IVF when compared with day 2 transfers 2931 (Scholtes and Zeilmaker 1996; Gardner et al., 1998; Jones et al., 1998) . In two of these studies where patient numbers of zona-intact blastocyst transfers were high, implantation rates of 23-25% were produced when two to four embryos were replaced. It was also claimed that after 5 days of culture, one to two zona-intact blastocysts can be replaced with a mean implantation rate of Ͼ23% per embryo, minimizing the incidence of triplets (Scholtes and Zeilmaker, 1996) . The implantation and multiple pregnancy rates of zona-manipulated blastocyst transfer in the present study appear to be much higher, suggesting that implantation may be further improved by enzymatic treatment of the zona.
It has been claimed that if assisted hatching by zona drilling is carried out before full blastocyst expansion or once hatching has commenced, profound consequences on embryonic development are expected in the form of loss of blastomeres through large holes in the zona (Cohen et al., 1990 ). This was not so when the zona was removed completely with enzymes in the present study, as no cells were disrupted prior to or while loading the catheter at the time of transfer. The junctions between the TE cells appeared to form a tight epithelium protecting the ICM within (Figure 2 ). It was interesting to note that if the zona was quickly removed in blastocysts in which the blastocoel was collapsing and the embryo then transferred to fresh medium, the majority of such blastocysts re-expanded with the formation of a large blastocoelic cavitỹ 1-2 h later, thus confirming the intactness and repair of the tight epithelium of the TE (Figure 3) .
Besides its other functions, the zona pellucida of cleaving embryos (day 2-4) prevents both the dispersal of blastomeres and direct contact between blastomeres and foreign cells (Bronson and McLaren, 1970) . Once blastocyst expansion has commenced with the formation of tight junctions between the peripheral cells of the embryo prior to implantation, it then appears that the zona is no longer necessary (Bronson and McLaren, 1970; Trounson and Moore, 1974) . In the mouse, around implantation in vivo, certain proteolytic enzymes may be released from the endometrium that first partially dissolve or soften the zona, followed by hatching per se (Cohen, 1992) . In the absence of such enzymes in vitro, it is therefore possible that changes in the composition of the zona occur which result in hardening and difficulties in hatching. The softening or complete removal of the zona with enzymes prior to blastocyst transfer may thus be a close simulation of what happens in vivo. Invasion of the naked blastocyst with foreign cells or agents may not pose a problem because of the tight epithelium of the TE protecting the ICM within. However, long exposures of the zona-free embryo to high concentrations of enzymes may damage such tight junctions and also surface microvilli, thereby disturbing metabolism and implantation (Figure 4a and b).
It was interesting to note that the 'in-vitro implantation' rate was 92% irrespective of the source and type of cells used as feeder layers (Table II; Figure 4c -f). It is then tempting to ask why IVF zona-intact embryos after transfer in vivo do not produce implantation rates as high. It is possible that the invitro changes to the zona pellucida interfere with hatching in vivo, or if enzymes are released by the endometrium at the time of implantation their concentrations may not be sufficient to dissolve an in-vitro-altered zona. The high 'in-vitro implantation rates' appeared to correlate to some extent with high invivo implantation rates in the present study. It is also possible that many of the zona-free blastocysts initially attach and invade the maternal endometrium in vivo, but detach before day 16-18 when the pregnancy is tested for rising HCG because of a hostile endometrium and suboptimal embryonic viability. Hitherto unknown other in-vivo factors may also be playing important contributory roles in implantation. If the transfer of good-quality zona-manipulated blastocysts is not able to improve implantation rates significantly in larger sample sizes, it is then important that thorough in-depth studies be carried out on the hostile endometrium to investigate specifically the embryo-maternal dialogue, receptors and priming of the endometrium, and the role of LIF. Answers to these questions are central to our understanding of implantation and improving IVF.
